Fundraising Fox

Anodyne

5 known investors

Find your way into Anodyne

Anodyne Nanotech develops the HeroPatch, a transdermal drug delivery system designed to replace traditional injections for chronic care treatments. The company focuses on simplifying medicine delivery through an alternative to needles and syringes.

BiotechHealthtechMedical Devices

Investors · 5

Bantam GroupWestwood
Big Pi VenturesAthens · $540K – $3.2M

Also in the syndicate · 3

Evercurious VCRelativity Healthcare PartnersVelocity Partners VClead

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeries AJun 2026

    Velocity Partners VC (lead), Evercurious VC, Relativity Healthcare Partners

    Source ↗
  • Undisclosed amountSeedMay 2024
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Anodyne Nanotech has filed a notice of an exempt offering of securities to raise $17,259,023.00 in New Funding. - intelligence360intelligence360.news · Jul 2026Patch, not needle: Anodyne raises $12.6m for GLP-1 obesity patchlongevity.technology · Jun 2026Anodyne Nanotech Raises $12.6 Million Series A To Advance Once-Weekly GLP-1 Patchpulse2.com · Jun 2026Anodyne Nanotech Raises $12.6M in Series A Fundingfinsmes.com · Jun 2026Anodyne Chemistries Announces $6.2M Seed Financing - Fort Capitalfortcapital.ca · May 2024Anodyne Nanotech Closes $4.2M Seed Financing - FinSMEsfinsmes.com · May 2021

Frequently asked questions

What does Anodyne do?
Anodyne Nanotech develops the HeroPatch, a transdermal drug delivery system designed to replace traditional injections for chronic care treatments. The company focuses on simplifying medicine delivery through an alternative to needles and syringes.
Who are Anodyne's investors?
Anodyne's investors include Bantam Group, Big Pi Ventures.